UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antivirale Prophylaxe bei onkologischen Therapien

InFo Hämatologie + Onkologie, 2021-03, Vol.24 (3), p.16-20

Sandherr, Michael

2021

Volltextzugriff (PDF)

Infektionsprophylaxe in der Hämatologie und Onkologie

InFo Hämatologie + Onkologie, 2021-03, Vol.24 (3), p.3-5

Sandherr, Michael

2021

Volltextzugriff (PDF)

Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

Haematologica (Roma), 2009-01, Vol.94 (1), p.113-122

2009

Volltextzugriff (PDF)

Infektionsprophylaxe in der Hämatologie und Onkologie

InFo Hämatologie + Onkologie, 2021-01, Vol.24 (3), p.3-5

Sandherr, Michael

2021

Volltextzugriff (PDF)

Infektionsmanagement in der Hämatologie und Onkologie

Onkologie (Heidelberg, Germany), 2022-04, Vol.28 (4), p.349-360

2022

Volltextzugriff (PDF)

Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature

European journal of medical research, 2011-04, Vol.16 (4), p.139-139

2011

Volltextzugriff (PDF)

2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy

European journal of cancer (1990), 2021-04, Vol.147, p.154-160

2021

Volltextzugriff (PDF)

Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

European journal of cancer (1990), 2020-11, Vol.140, p.86-104

2020

Volltextzugriff (PDF)

Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

Annals of hematology, 2015-09, Vol.94 (9), p.1441-1450

2015

Volltextzugriff (PDF)

Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus

Annals of hematology, 2022-03, Vol.101 (3), p.491-511

2022

Volltextzugriff (PDF)

Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

Annals of hematology, 2014-09, Vol.93 (9), p.1449-1456

2014

Volltextzugriff (PDF)

Infektionen stoppen und Komplikationen vermeiden: Antimikrobielle Therapie bei Patienten mit malignen Erkrankungen

Uro-news, 2010-01, Vol.14 (1), p.46-52

2010

Volltextzugriff (PDF)

Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO)

Annals of oncology, 2006-07, Vol.17 (7), p.1051-1059

2006

Volltextzugriff (PDF)

A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLL

Annals of hematology, 2009-03, Vol.88 (3), p.221-227

2009

Volltextzugriff (PDF)

Elevated RIPK3 correlates with disease burden in myelofibrosis

Blood advances, 2023-04, Vol.7 (7), p.1219-1224

2023

Volltextzugriff (PDF)

Oncological therapy in the elderly

MMW Fortschritte der Medizin, 2007-09, Vol.149 (35-36), p.35-37

Sandherr, Michael

2007

Volltextzugriff (PDF)

Infektionsmanagement in der Hämatologie und Onkologie: Verantwortungsvoller Einsatz von Antiinfektiva

Der Onkologe, 2022-04, Vol.28 (4), p.349-360

2022

Volltextzugriff (PDF)

Management of infections in patients with cancer

Der Onkologe, 2022-01, Vol.28 (4), p.349-360

2022

Volltextzugriff (PDF)

Clinical Practice Guideline: Follicular Lymphoma—Diagnosis, Treatment, and Follow-up

Deutsches Ärzteblatt international, 2021-04, Vol.118 (Forthcoming)

2021

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink (Online service)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(43)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(36)
Deutsch
(9)

Erscheinungsjahr

n.n

Thema

Humans
(27)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Hematology
(18)
Oncology
(15)
Middle Aged
(12)
Biological And Medical Sciences
(9)
Female
(9)
Medical Sciences
(9)
Adult
(8)
Aged
(8)
Male
(8)
Hematologic And Hematopoietic Diseases
(7)
Medicine
(7)
Medicine & Public Health
(7)
Germany
(6)
Infectious Diseases
(6)
Neoplasms - Therapy
(5)
Societies, Medical
(5)
Adolescent
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Hematology
(11)
Blood
(5)
Der Onkologe
(3)
European Journal Of Cancer
(3)
Info Hämatologie + Onkologie
(3)
Journal Of Clinical Oncology
(2)
Onkologie
(2)
American Journal Of Clinical Oncology
(1)
Annals Of Oncology
(1)
Blood Advances
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antivirale Prophylaxe bei onkologischen Therapien

Infektionsprophylaxe in der Hämatologie und Onkologie

Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial

Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

Infektionsprophylaxe in der Hämatologie und Onkologie

Infektionsmanagement in der Hämatologie und Onkologie

Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature

2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants

Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

Infektionen stoppen und Komplikationen vermeiden: Antimikrobielle Therapie bei Patienten mit malignen Erkrankungen

Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO)

A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLL

Elevated RIPK3 correlates with disease burden in myelofibrosis

Oncological therapy in the elderly

Infektionsmanagement in der Hämatologie und Onkologie: Verantwortungsvoller Einsatz von Antiinfektiva

Management of infections in patients with cancer

Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Clinical Practice Guideline: Follicular Lymphoma—Diagnosis, Treatment, and Follow-up

Aktive Filter

Suchergebnisse filtern